Immuneering Corporation
IMRX
$5.96
$0.0350.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.26% | 8.44% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.69% | -16.56% | |||
| Operating Income | 4.69% | 16.56% | |||
| Income Before Tax | 4.07% | 16.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.07% | 16.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.07% | 16.65% | |||
| EBIT | 4.69% | 16.56% | |||
| EBITDA | 4.72% | 16.64% | |||
| EPS Basic | 5.29% | 27.16% | |||
| Normalized Basic EPS | 5.29% | 27.14% | |||
| EPS Diluted | 5.29% | 27.16% | |||
| Normalized Diluted EPS | 5.29% | 27.14% | |||
| Average Basic Shares Outstanding | 1.28% | 14.43% | |||
| Average Diluted Shares Outstanding | 1.28% | 14.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||